nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.27	0.275	CbGbCtD
Erythromycin—SLCO1A2—Cyclosporine—focal segmental glomerulosclerosis	0.241	0.245	CbGbCtD
Erythromycin—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.134	0.136	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.134	0.136	CbGbCtD
Erythromycin—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.1	0.102	CbGbCtD
Erythromycin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0652	0.0663	CbGbCtD
Erythromycin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0391	0.0397	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.000542	0.132	CbGeAlD
Erythromycin—SLC22A7—kidney—focal segmental glomerulosclerosis	0.000517	0.126	CbGeAlD
Erythromycin—SLC22A7—cortex of kidney—focal segmental glomerulosclerosis	0.000503	0.123	CbGeAlD
Erythromycin—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.000464	0.113	CbGeAlD
Erythromycin—MLNR—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.000394	0.0385	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.000387	0.0378	CbGpPWpGaD
Erythromycin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—focal segmental glomerulosclerosis	0.000365	0.0357	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000353	0.0344	CbGpPWpGaD
Erythromycin—SLCO1A2—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000336	0.0328	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00033	0.0322	CbGpPWpGaD
Erythromycin—SLCO1A2—kidney—focal segmental glomerulosclerosis	0.000313	0.0763	CbGeAlD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000303	0.0296	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000302	0.0294	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000298	0.0291	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000295	0.0288	CbGpPWpGaD
Erythromycin—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.117	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00027	0.0263	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00026	0.0254	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000256	0.025	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000252	0.0246	CbGpPWpGaD
Erythromycin—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.00025	0.061	CbGeAlD
Erythromycin—SLCO1A2—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000249	0.0243	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000233	0.0228	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000229	0.0223	CbGpPWpGaD
Erythromycin—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000224	0.0548	CbGeAlD
Erythromycin—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.000223	0.0544	CbGeAlD
Erythromycin—MLNR—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000212	0.0207	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000209	0.0205	CbGpPWpGaD
Erythromycin—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.0803	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.0002	0.0195	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000198	0.0193	CbGpPWpGaD
Erythromycin—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000197	0.0481	CbGeAlD
Erythromycin—CYP2B6—kidney—focal segmental glomerulosclerosis	0.000196	0.0478	CbGeAlD
Erythromycin—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000192	0.0469	CbGeAlD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00019	0.0185	CbGpPWpGaD
Erythromycin—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.0723	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000169	0.0165	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000152	0.0148	CbGpPWpGaD
Erythromycin—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000148	0.0361	CbGeAlD
Erythromycin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.0586	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000141	0.0137	CbGpPWpGaD
Erythromycin—SLCO1A2—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.00013	0.0127	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000129	0.0126	CbGpPWpGaD
Erythromycin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000125	0.0122	CbGpPWpGaD
Erythromycin—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000119	0.0291	CbGeAlD
Erythromycin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.0464	CcSEcCtD
Erythromycin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000113	0.0453	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000112	0.011	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000112	0.0109	CbGpPWpGaD
Erythromycin—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00011	0.0441	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000107	0.0104	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000106	0.0103	CbGpPWpGaD
Erythromycin—ABCB1—kidney—focal segmental glomerulosclerosis	0.000105	0.0256	CbGeAlD
Erythromycin—MLNR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000102	0.00997	CbGpPWpGaD
Erythromycin—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000102	0.0249	CbGeAlD
Erythromycin—MLNR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000101	0.00991	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	9.7e-05	0.00947	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	9.4e-05	0.00917	CbGpPWpGaD
Erythromycin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	8.6e-05	0.0343	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	8.59e-05	0.00839	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	8.53e-05	0.00833	CbGpPWpGaD
Erythromycin—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	8.41e-05	0.0336	CcSEcCtD
Erythromycin—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	8.31e-05	0.00811	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.2e-05	0.008	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	7.8e-05	0.00762	CbGpPWpGaD
Erythromycin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	7.62e-05	0.0304	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.29e-05	0.00711	CbGpPWpGaD
Erythromycin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	7.02e-05	0.028	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.62e-05	0.00646	CbGpPWpGaD
Erythromycin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	6.55e-05	0.0261	CcSEcCtD
Erythromycin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	6.27e-05	0.025	CcSEcCtD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	6.23e-05	0.00608	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.05e-05	0.0059	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.03e-05	0.00589	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.99e-05	0.00585	CbGpPWpGaD
Erythromycin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	5.99e-05	0.0239	CcSEcCtD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	5.57e-05	0.00544	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	5.51e-05	0.00538	CbGpPWpGaD
Erythromycin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	5.49e-05	0.0219	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.49e-05	0.00536	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	5.39e-05	0.00526	CbGpPWpGaD
Erythromycin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	5.3e-05	0.0211	CcSEcCtD
Erythromycin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	5.2e-05	0.0208	CcSEcCtD
Erythromycin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	5.14e-05	0.0205	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.04e-05	0.00492	CbGpPWpGaD
Erythromycin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	5.03e-05	0.0201	CcSEcCtD
Erythromycin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	4.99e-05	0.0199	CcSEcCtD
Erythromycin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	4.76e-05	0.019	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	4.62e-05	0.00451	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.61e-05	0.0045	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.42e-05	0.00431	CbGpPWpGaD
Erythromycin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	4.34e-05	0.0173	CcSEcCtD
Erythromycin—Pain—Cyclosporine—focal segmental glomerulosclerosis	4.27e-05	0.017	CcSEcCtD
Erythromycin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	4.11e-05	0.0164	CcSEcCtD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	4.11e-05	0.00401	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.09e-05	0.00399	CbGpPWpGaD
Erythromycin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	4.08e-05	0.0163	CcSEcCtD
Erythromycin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	3.96e-05	0.0158	CcSEcCtD
Erythromycin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	3.94e-05	0.0157	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.91e-05	0.00382	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.79e-05	0.0037	CbGpPWpGaD
Erythromycin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	3.68e-05	0.0147	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.59e-05	0.00351	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.59e-05	0.0035	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.57e-05	0.00349	CbGpPWpGaD
Erythromycin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	3.53e-05	0.0141	CcSEcCtD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.44e-05	0.00336	CbGpPWpGaD
Erythromycin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	3.41e-05	0.0136	CcSEcCtD
Erythromycin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	3.3e-05	0.0132	CcSEcCtD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.3e-05	0.00322	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.24e-05	0.00317	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.22e-05	0.00314	CbGpPWpGaD
Erythromycin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	3.17e-05	0.0127	CcSEcCtD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.15e-05	0.00307	CbGpPWpGaD
Erythromycin—Rash—Cyclosporine—focal segmental glomerulosclerosis	3.15e-05	0.0126	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3e-05	0.00293	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.97e-05	0.0029	CbGpPWpGaD
Erythromycin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	2.96e-05	0.0118	CcSEcCtD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.83e-05	0.00276	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.68e-05	0.00262	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.49e-05	0.00244	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	2.31e-05	0.00226	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.18e-05	0.00213	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.08e-05	0.00203	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.96e-05	0.00192	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.91e-05	0.00187	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.88e-05	0.00184	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.87e-05	0.00182	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.82e-05	0.00178	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.68e-05	0.00164	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.59e-05	0.00155	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.57e-05	0.00154	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.43e-05	0.0014	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.43e-05	0.0014	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.41e-05	0.00138	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.4e-05	0.00137	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.36e-05	0.00133	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.29e-05	0.00126	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.29e-05	0.00126	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.26e-05	0.00123	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.25e-05	0.00122	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.22e-05	0.0012	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.22e-05	0.00119	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.16e-05	0.00113	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.1e-05	0.00107	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.08e-05	0.00105	CbGpPWpGaD
Erythromycin—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	1.04e-05	0.00102	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.01e-05	0.000989	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—LPL—focal segmental glomerulosclerosis	9.71e-06	0.000948	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	9.28e-06	0.000906	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	9.24e-06	0.000902	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	9.03e-06	0.000882	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	8.74e-06	0.000853	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AGT—focal segmental glomerulosclerosis	8.31e-06	0.000811	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	8.15e-06	0.000796	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	8.13e-06	0.000794	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	7.95e-06	0.000776	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	7.62e-06	0.000744	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.49e-06	0.000732	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	7.48e-06	0.00073	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.45e-06	0.000728	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.32e-06	0.000715	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	6.86e-06	0.00067	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.81e-06	0.000665	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	6.52e-06	0.000637	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ALB—focal segmental glomerulosclerosis	6.38e-06	0.000622	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.38e-06	0.000622	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6e-06	0.000586	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.83e-06	0.000569	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	5.74e-06	0.00056	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	5.64e-06	0.00055	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.53e-06	0.00054	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	5.51e-06	0.000538	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	5.44e-06	0.000531	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	5e-06	0.000489	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.89e-06	0.000478	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	4.82e-06	0.000471	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.79e-06	0.000468	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	4.71e-06	0.00046	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.41e-06	0.000431	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	4.33e-06	0.000423	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.2e-06	0.00041	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.16e-06	0.000406	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	3.7e-06	0.000361	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.7e-06	0.000361	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	3.62e-06	0.000353	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.56e-06	0.000347	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.4e-06	0.000332	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	3.32e-06	0.000324	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.84e-06	0.000277	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.73e-06	0.000266	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.56e-06	0.00025	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.19e-06	0.000214	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	2.18e-06	0.000213	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.68e-06	0.000164	CbGpPWpGaD
